Loading insider details...
Beta
Latest Form 4 (Sep 30, 2026): Sale of 31,550 DFTX shares, $1.15M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Definium Therapeutics, Inc. (DFTX) | Sale | 31,550 | $1.15M |
| Sep 14, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 750,000 | n/a |
| Sep 5, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 40,000 | n/a |
| Aug 12, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 375,000 | n/a |
| Jun 26, 2026 | Definium Therapeutics, Inc. (DFTX) | Sale | 29,208 | $1.32M |
| Jun 22, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 375,000 | n/a |
| Mar 26, 2026 | Definium Therapeutics, Inc. (DFTX) | Sale | 24,431 | $451.2K |
| Feb 5, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 320,000 | n/a |
| Dec 29, 2025 | Mind Medicine (MindMed) Inc. (MNMD) | Sale | 25,791 | $339.1K |
| Sep 26, 2025 | Mind Medicine (MindMed) Inc. (MNMD) | Sale | 25,797 | $252.0K |